Diseases, Conditions, Syndromes

FDA panel to decide on novavax COVID vaccine

A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of Novavax's COVID-19 vaccine on Tuesday.

Diseases, Conditions, Syndromes

Expert discusses progress of mRNA vaccines

Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against COVID-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered ...

page 15 from 40